Ausiello Dennis A
Insider CIK 1381994 · ALNY Director · MCRB Director · RANI Director · PFE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2026-07-08 | 2026-07-10 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2026-07-01 | 2026-07-02 | 7,508 | — | $0 | 7,508 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2026-05-28 | 2026-06-01 | 123,600 | — | $0 | 123,600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-05-20 | 2026-05-22 | 1,441 | — | $0 | 1,441 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-05-20 | 2026-05-22 | 671 | — | $0 | 1,582 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-14 | 2025-08-15 | 9,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-14 | 2025-08-15 | 3,454 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-14 | 2025-08-15 | 5,153 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-14 | 2025-08-15 | 4,581 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-14 | 2025-08-15 | 5,228 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-08-14 | 2025-08-15 | 4,032 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 1,205 | $441.88 | $532.5K | 1,552 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 1,238 | $440.54 | $545.4K | 2,757 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 5,302 | $439.27 | $2.33M | 3,995 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 2,086 | $438.34 | $914.4K | 9,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 1,922 | $437.56 | $841.0K | 11,383 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 5,358 | $436.00 | $2.34M | 13,305 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 7,675 | $435.40 | $3.34M | 18,663 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 2,098 | $434.50 | $911.6K | 26,338 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 1,938 | $432.94 | $839.0K | 28,436 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 1,985 | $430.81 | $855.2K | 30,374 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-14 | 2025-08-15 | 3,454 | $189.87 | $655.8K | 32,359 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-14 | 2025-08-15 | 4,032 | $171.95 | $693.3K | 28,905 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-14 | 2025-08-15 | 5,228 | $151.22 | $790.6K | 24,873 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-14 | 2025-08-15 | 4,581 | $148.77 | $681.5K | 19,645 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-14 | 2025-08-15 | 641 | $442.66 | $283.7K | 911 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-14 | 2025-08-15 | 5,153 | $128.31 | $661.2K | 15,064 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-08-14 | 2025-08-15 | 9,000 | $72.01 | $648.1K | 9,911 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2025-07-01 | 2025-07-02 | 6,452 | — | $0 | 6,452 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2025-05-28 | 2025-05-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-05-08 | 2025-05-12 | 1,558 | — | $0 | 1,558 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-05-08 | 2025-05-12 | 775 | — | $0 | 911 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2024-12-16 | 2024-12-17 | 15,423 | — | $0 | 79,317 | SEC↗ |
| RANI Rani Therapeutics Holdings | D To issuer deriv | 2024-12-16 | 2024-12-17 | 101,276 | — | $0 | 0 | SEC↗ |
| RANI Rani Therapeutics Holdings | D To issuer deriv | 2024-12-16 | 2024-12-17 | 15,423 | — | $0 | 0 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2024-12-16 | 2024-12-17 | 101,276 | — | $0 | 101,276 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-08-06 | 2024-08-08 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-08-06 | 2024-08-08 | 9,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-08-06 | 2024-08-08 | 9,000 | $105.26 | $947.3K | 20,386 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-08-06 | 2024-08-08 | 11,250 | $131.21 | $1.48M | 11,386 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 262 | $266.45 | $69.8K | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 632 | $264.95 | $167.4K | 398 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 3,408 | $263.72 | $898.8K | 1,030 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 4,367 | $262.79 | $1.15M | 4,438 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 6,212 | $261.63 | $1.63M | 8,805 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 3,742 | $260.40 | $974.4K | 15,017 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-08-06 | 2024-08-08 | 1,627 | $259.56 | $422.3K | 18,759 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2024-07-01 | 2024-07-03 | 64,564 | — | $0 | 64,564 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2024-05-29 | 2024-05-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-05-16 | 2024-05-20 | 5,228 | — | $0 | 5,228 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2024-04-04 | 2024-04-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2023-12-16 | 2023-12-19 | 101,276 | — | $0 | 101,276 | SEC↗ |
| RANI Rani Therapeutics Holdings | D To issuer deriv | 2023-12-16 | 2023-12-19 | 101,276 | — | $0 | 0 | SEC↗ |
| RANI Rani Therapeutics Holdings | D To issuer deriv | 2023-12-16 | 2023-12-19 | 15,423 | — | $0 | 63,894 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2023-12-16 | 2023-12-19 | 15,423 | — | $0 | 15,423 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2023-05-25 | 2023-05-30 | 101,276 | — | $0 | 101,276 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-11-21 | 2022-11-23 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2022-11-21 | 2022-11-23 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-11-21 | 2022-11-23 | 11,250 | $71.99 | $809.9K | 22,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2022-11-21 | 2022-11-23 | 11,250 | $70.20 | $789.8K | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2022-11-21 | 2022-11-23 | 22,500 | $220.00 | $4.95M | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RANI Rani Therapeutics Holdings | A Award deriv | 2022-05-25 | 2022-05-27 | 41,416 | — | $0 | 41,416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-05-18 | 2022-05-20 | 5,153 | — | $0 | 5,153 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 136 | — | $0 | 136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-07-15 | 2021-07-19 | 4,032 | — | $0 | 4,032 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-21 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-07-01 | 2020-07-06 | 4,581 | — | $0 | 4,581 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2019-06-13 | 2019-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2018-06-26 | 2018-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2018-04-26 | 2018-04-30 | 5,224 | $36.85 | $192.5K | 47,346 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 2,117 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-13 | 2018-03-14 | 17,117 | $150.00 | $2.57M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 15,000 | $59.25 | $888.8K | 17,117 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 2,117 | $63.86 | $135.2K | 2,117 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-11-02 | 2017-11-03 | 20,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-11-02 | 2017-11-03 | 20,000 | $30.09 | $601.8K | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-02 | 2017-11-03 | 20,000 | $130.00 | $2.60M | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2017-04-27 | 2017-04-28 | 5,538 | $33.86 | $187.5K | 42,122 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2016-06-15 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2016-04-28 | 2016-04-29 | 5,697 | $32.91 | $187.5K | 36,584 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2015-06-25 | 2015-06-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2015-04-23 | 2015-04-24 | 4,596 | $35.36 | $162.5K | 30,887 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-04-21 | 2015-04-23 | 8,165 | $130.02 | $1.06M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-19 | 2015-03-19 | 5,000 | $120.00 | $600.0K | 8,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-03-05 | 2015-03-06 | 706 | — | $0 | 2,117 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-05 | 2015-03-06 | 706 | $115.00 | $81.2K | 13,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-03-05 | 2015-03-06 | 706 | $63.86 | $45.1K | 13,871 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-08 | 2014-12-10 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-08 | 2014-12-10 | 5,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-08 | 2014-12-10 | 10,000 | $30.09 | $300.9K | 28,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-08 | 2014-12-10 | 5,000 | $30.09 | $150.4K | 18,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-08 | 2014-12-10 | 5,000 | $105.00 | $525.0K | 23,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-08 | 2014-12-10 | 10,000 | $110.00 | $1.10M | 13,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-11-11 | 2014-11-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-11-11 | 2014-11-13 | 5,000 | $100.00 | $500.0K | 13,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-11-11 | 2014-11-13 | 5,000 | $30.09 | $150.4K | 18,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-10-22 | 2014-10-24 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-10-22 | 2014-10-24 | 5,000 | $30.09 | $150.4K | 18,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-10-22 | 2014-10-24 | 5,000 | $90.00 | $450.0K | 13,165 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-06-05 | 2014-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2014-04-24 | 2014-04-28 | 5,291 | $30.71 | $162.5K | 26,291 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-01-02 | 2014-01-03 | 2,823 | — | $0 | 2,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-06-06 | 2013-06-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |